ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
128 hedge funds and large institutions have $443M invested in Intercept Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
-22
Holders Change %
-14.67%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
52
Reduced
31
Closed
34
Calls
$22.2M
Puts
$16.7M
Net Calls
+$5.47M
Net Calls Change
+$12.6M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$11.5M |
| 2 |
2
Two Sigma Investments
New York
|
$8.83M |
| 3 |
3
Rockefeller Capital Management
New York
|
$3.56M |
| 4 |
4
Two Sigma Advisers
New York
|
$9.94M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$22.1M |
Top Sellers
| 1 |
1
First Trust Advisors
Wheaton,
Illinois
|
$492K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$1.66M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$51.5M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$53.1M |
| 5 |
5
BlackRock
New York
|
$46.8M |
